|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02.02.26 - 22:36
|
DaVita Inc. Q4 Sales Increase (AFX)
|
|
|
WASHINGTON (dpa-AFX) - DaVita Inc. (DVA) released a profit for fourth quarter of $234.21 millionThe company's earnings totaled $234.21 million, or $3.29 per share. This compares with $259.32 milli......
|
|
|
|
|
02.02.26 - 22:06
|
DaVita Inc. 4th Quarter 2025 Results (PR Newswire)
|
|
|
DENVER, Feb. 2, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2025. "Our strong platform delivered once again in 2025, providing high quality, innovative care to our patients and achieving the financial......
|
|
|
02.02.26 - 21:03
|
Elara Caring Secures New Strategic Investment from Ares and DaVita (Business Wire)
|
|
|
Partnership will accelerate Elara's growth and evolution as home health care leader; expand access to high-acuity care for complex diseases through new offeringsDALLAS--(BUSINESS WIRE)--Elara Caring (Elara), a leading national provider of skilled home health, hospice, behavioral health, and personal care services, today announced that it has entered into an agreement for a strategic investment from Ares' Private Equity Group (Ares) and DaVita. The investment is intended to expand access to personalized, clinically advanced care at home for patients with complex and acute needs. Elara will continue to operate as a wholly independent company led by CEO Ananth Mohan and the current management team. Following the closing, the parties will collaborate to help Elara expand access to care through new care models and clinical programs.
The investment from Ares and DaVita will support Elara's next phase of growth by helping to expand its capacity to deliver specialized, in-home care and launch innovative care m...
|
|
|
|
|
|
|
|
|
|
|
|
|
21.01.26 - 16:01
|
DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call (PR Newswire)
|
|
|
DENVER, Jan. 21, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Monday, February 2, 2026 at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.......
|
|
|
|
|
|
|
14.01.26 - 16:36
|
FME: Davita und Grippe bremsen Aktie aus (Der Aktionaer)
|
|
|
Der Dialyse-Spezialist Fresenius Medical Care (FME) ist am Mittwoch mit einem dicken Minus von über fünf Prozent der schwächste Wert im deutschen Leitindex. Die Aktie wird in Sippenhaft genommen und muss darüber hinaus den frühzeitigen Beginn der Grippesaison in den USA verkraften....
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
